Thomas Davis M.D.

Senior Vice President of Clinical Development and Chief Medical Officer

Dr. Thomas Davis is Senior Vice President of Clinical Development and Chief Medical Officer for Celldex Therapeutics. Dr. Davis was formerly Chief Medical Officer at GenVec, and Senior Director of Clinical Science at Medarex. He has supervised clinical efforts in adult hematologic malignancies and marrow transplantation and therapeutic antibodies at the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) and worked with Dr. Ron Levy on the development of rituximab and idiotype vaccines at Stanford University.